ASKLEPIOS Course on Cardio-Thoracic Imaging Biomarkers

December 10-11, 2018; Valencia/Spain
Course informationThis course aims to familiarise radiology residents in their final years of training and board-certified radiologists with cutting-edge clinical and quantitative imaging technology. The two-day course addresses the development of radiomics and imaging biomarkers in clinical practice, focusing on the precise and accurate analysis of lung tumours, diffuse lung diseases and cardiac disorders. The role of quantitative imaging in clinical trials, treatment effects and toxicity will be defined. The course will cover the clinical needs, technical solutions and practical implementation aspects. Also, the main biases in validating and reporting imaging data will be covered. Moreover, the course will discuss the state of the art of imaging biomarkers in these organs and how they should be implemented in daily clinical practice. A unique group of European faculty members, well known for their experience in applying novel imaging biomarkers, will offer top quality didactic lectures followed by technical considerations and clinical impact discussions in small groups.

Learning objectives

  • to understand different radiomic features and imaging biomarkers as spatially and temporally resolved surrogate indicators, representing virtual biopsies in different cardio-thoracic pathologies
  • to critically evaluate the imaging biomarkers information related to individual patients' biological situation, clinical problems and treatment effects
  • to assess the correlation, specificity and biases between surrogate imaging biomarkers and the different underlying processes

       Programme flyer including learning objectives by topic

Monday, December 10
12:45-13:00 Welcome and introduction
  General concepts
13:00-13:30    Concept and development of radiomics and imaging biomarkers
L. Marti-Bonmati, Valencia/ES
13:30-14:00 Measurement, accuracy, precision, confusion and validation
A. Alberich-Bayarri, Valencia/ES
Structure report in cardiac and thoracic imaging and quantitation
L. Marti-Bonmati, Valencia/ES
14:30-15:00 Coffee break
  Lung oncology
15:00-15:30 Lung cancer: biology, genetics, imaging, therapy
H.-U. Kauczor, Heidelberg/DE
15:30-16:00 Metrics in lung cancer oncology
S. Schäfer, Heidelberg/DE
16:00-16:30 Tumour response
H.-U. Kauczor, Heidelberg/DE
16:30-18:00 Workshops
H.-U. Kauczor, S. Schäfer
Closing remarks
Tuesday, December 11
  Cardiac diseases
08:30-09:00    Myocardial fibrosis
C. Loewe, Vienna/AT
09:00-09:30 Imaging extracted parameters in cardiac magnetic resonance imaging
U. Reiter, Graz/AT
Valvular diseases
C. Loewe, Vienna/AT
10:00-10:30 Coffee break
10:30-12:00 Workshops
C. Loewe, U. Reiter 
  Clinical trials
Imaging biomarkers in clinical trials and treatment effects
Y. Liu, Valbonne/FR
12:30-13:30 Lunch break
  Lung diffuse diseases
13:30-14:00 COPD: biology, imaging, therapy
C. Muñoz, Valencia/ES
14:00-14:30 Quantitative diffuse lung biomarkers
A. Alberich-Bayarri, Valencia/ES
Diffuse interstitial pulmonary disease
C. Muñoz, Valencia/ES
Coffee break
15:30-17:00 Workshops
C. Muñoz, A. Alberich-Bayarri
  Clinical trials
Imaging biomarkers in clinical trials and drug toxicity
Y. Liu, Valbonne/FR
Closing remarks and certificate of attendance
Back to overview

About ESOR

... an established and growing institution, fulfilling the mission of the European Society of Radiology (ESR) in the field of education.

                     Anastas Doreski, Skopje/MK

            Enrique F. Garces-Inigo, Albacete/ES

         Bruno Hochhegger, Porto Alegre/BR

            Saulius Rutkauskas, Kaunas/LT
ESR Contact
  • ESR Office:
  • Am Gestade 1
  • 1010 Vienna, Austria
  • Tel: +43-1-533 40 64
  • Fax: +43-1-533 40 64-447
The European School
of Radiology (ESOR)
is an initiative of the
European Society of